Battelle Pulmonary Therapeutics Announces Research Agreement with Eiffel Technologies Limited.Business Editors & Health/Medical Writers BIOWIRE2K COLUMBUS, Ohio--(BW HealthWire)--Dec. 20, 2001 Battelle Pulmonary Therapeutics Inc. (BPT BPT Bridgeport (Connecticut) BPT Best Practicable Control Technology BPT Best Practicable Control Technology Currently Available BPT BP Prudhoe Bay Royalty Trust (stock symbol) BPT Boston Playwrights' Theatre ) today announced that it has signed a research collaboration agreement with Eiffel Research & Development Pty Ltd (ERD), a subsidiary of Melbourne, Australia-based Eiffel Technologies Limited. Under the terms of the agreement, ERD will use its Super Critical Fluid (SCF SCF Service Canadien des Forêts (Canadian Forest Service) SCF Stem Cell Factor SCF Scientific Committee on Food (European Commission) SCF Service Canadien de la Faune ) technology to produce and supply sub-micron size drug particles of a protein for testing in BPT's proprietary electrohydrodynamic (EHD EHD epizootic hemorrhagic disease. ) or Mystic(TM) pulmonary delivery device. "We believe the combination of the SCF technology and our Mystic delivery system will enhance the performance and bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration. bi·o·a·vail·a·bil·i·ty n. of BPT's proprietary drugs and those we have in development with our pharmaceutical partners," said Donna Palmer, vice president, pharmaceutical research and development for BPT. "Nanoparticle technology allows us to continue to leverage Mystic's ability to control and deliver fine aerosol droplets and maintain a consistent and high drug load." EHD is BPT's proprietary approach to aerosolizing liquids for pulmonary delivery of drugs. The Mystic device delivers particles directly to the lungs with better than 90 percent efficiency, and without the need for liquid propellants or other pressurized pres·sur·ize tr.v. pres·sur·ized, pres·sur·iz·ing, pres·sur·iz·es 1. To maintain normal air pressure in (an enclosure, as an aircraft or submarine). 2. systems. The device comes in small, convenient sizes and can be adapted to deliver a wide range of medications. EHD inhalers provide efficient, accurate, and reproducible dosing and have optimal ergonomics. About BPT Battelle Pulmonary Therapeutics Inc. is a specialty pharmaceutical company leveraging science and engineering for more effective medicines. Using its proprietary Mystic(TM) technology, the company develops its own products in cancer and asthma and has development agreements with leading pharmaceutical companies for asthma, COPD COPD chronic obstructive pulmonary disease. COPD abbr. chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) , respiratory infections and systemic diseases. BPT is a pre-public subsidiary of Battelle Memorial Institute The Battelle Memorial Institute is a private not-for-profit applied science and technology development company headquartered in Columbus, Ohio. The institute opened in 1929 but traces its origins to the 1923 will of Ohio industrialist Gordon Battelle which provided for its , the world's largest research and consulting organization. For more information on BPT, reference the company's website at www.bpt-inc.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion